These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 33151101)

  • 1. Pharmacokinetics, tissue distribution and excretion of a novel long-acting human insulin analogue - recombinant insulin LysArg in rats.
    Cui T; Li Y; Wei Z; Zhang X; Li W; Zhou W; Lu J; Li J; Yi X; Zeng Y; Liu C; Yan F
    Xenobiotica; 2021 Mar; 51(3):307-315. PubMed ID: 33151101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, Pharmacokinetics, Biodistribution and Excretion of a Novel Acylated Long-Acting Insulin Analogue INS061 in Rats.
    Pan K; Shi X; Liu K; Wang J; Chen Y
    Drug Des Devel Ther; 2021; 15():3487-3498. PubMed ID: 34408401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of [125I]-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats.
    Uchida T; Aoyama K; Mori K; Usui T; Watanabe T; Takariki Y; Asahara N; Hirose M; Kimura T; Tateishi M; Higuchi S
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):403-10. PubMed ID: 9842984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, tissue distribution and excretion of recombinant human parathyroid hormone 1-84 in animals.
    Bai H; Jing D; Jiang H; Yin S
    Cell Biochem Biophys; 2013 Jun; 66(2):379-87. PubMed ID: 23314825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human parathyroid hormone 1-34: pharmacokinetics, tissue distribution and excretion in rats.
    Hu Z; Niu H; Yang X; Li H; Sang G; Li B
    Int J Pharm; 2006 Jul; 317(2):144-54. PubMed ID: 16621369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of PEGylated recombinant human endostatin (M2ES) in rats.
    Li ZG; Jia L; Guo LF; Yu M; Sun X; Nie W; Fu Y; Rao CM; Wang JZ; Luo YZ
    Acta Pharmacol Sin; 2015 Jul; 36(7):847-54. PubMed ID: 26027657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of radiolabelled recombinant human insulin-like growth factor binding protein-3 from the circulation, and its distribution amongst organs and tissues in adult male rats.
    Arany E; Zabel P; Freeman D; Hill DJ
    Regul Pept; 1993 Oct; 48(1-2):133-43. PubMed ID: 7505460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, excretion, distribution, and metabolism of 60-kDa polyethylene glycol used in BAY 94-9027 in rats and its value for human prediction.
    Baumann A; Piel I; Hucke F; Sandmann S; Hetzel T; Schwarz T
    Eur J Pharm Sci; 2019 Mar; 130():11-20. PubMed ID: 30654111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of recombinant human bifunctional peptidylglycine α-amidating monooxygenase in CHO cells and its use for insulin analogue modification.
    Zieliński M; Wójtowicz-Krawiec A; Mikiewicz D; Kęsik-Brodacka M; Cecuda-Adamczewska V; Marciniak-Rusek A; Sokołowska I; Łukasiewicz N; Gurba L; Odrowąż-Sypniewski M; Baran P; Płucienniczak G; Płucienniczak A; Borowicz P; Szewczyk B
    Protein Expr Purif; 2016 Mar; 119():102-9. PubMed ID: 26614892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, tissue distribution, and excretion of FGF-21 following subcutaneous administration in rats.
    He Y; Li Y; Wei Z; Zhang X; Gao J; Wang X; Li X; Wu W; Li W; Yi X; Zeng Y; Liu C
    Drug Test Anal; 2018 Feb; ():. PubMed ID: 29399989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of [125I]-recombinant human interleukin-11: 2. Placental transfer and excretion into milk after subcutaneous administration to rats.
    Uchida T; Aoyama K; Mori K; Usui T; Watanabe T; Takariki Y; Asahara N; Hirose M; Kimura T; Tateishi M; Higuchi S
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):411-6. PubMed ID: 9842985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.
    Vora JP; Owens DR; Dolben J; Atiea JA; Dean JD; Kang S; Burch A; Brange J
    BMJ; 1988 Nov; 297(6658):1236-9. PubMed ID: 3145064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of PEG recombinant human interleukin-6 in rats].
    He XL; Yang G; Yin HL; Zhang XM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):149-52. PubMed ID: 19292067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption kinetics of short- and intermediate-acting insulins after jet injection with Medi-Jector II.
    Houtzagers CM; Berntzen PA; van der Stap H; Heine RJ; van der Veen EA
    Diabetes Care; 1988 Oct; 11(9):739-42. PubMed ID: 3066607
    [No Abstract]   [Full Text] [Related]  

  • 15. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of human insulin.
    Heinemann L; Richter B
    Diabetes Care; 1993 Dec; 16 Suppl 3():90-100. PubMed ID: 8299482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why Do Some Concentrated Insulins Maintain Their Pharmacokinetics/Pharmacodynamics Profile?
    Hood RC
    Diabetes Technol Ther; 2017 Apr; 19(4):203-205. PubMed ID: 28418731
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the plasma pharmacokinetics, tissue distribution, excretion and effects on cholesterol pharmacokinetics of a novel hydrophilic compound, FM-VP4, following administration to rats.
    Wasan KM; Peteherych KD; Najafi S; Zamfir C; Pritchard PH
    J Pharm Pharm Sci; 2001; 4(3):207-16. PubMed ID: 11737986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304.
    Heinemann L; Sinha K; Weyer C; Loftager M; Hirschberger S; Heise T
    Diabet Med; 1999 Apr; 16(4):332-8. PubMed ID: 10220208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.